Cancer represents a group of heterogeneous diseases characterized by uncontrolled
growth and spread of abnormal cells, ultimately leading to death. Nanomedicine plays a …

There is increasing evidence that malignant tumors are initiated and maintained by a sub-
population of tumor cells that have similar biological properties to normal adult stem cells …

Nanoparticles (NPs) are encapsulating agents that exist in the nanometer range. They can
be classified into different classes based on their properties, shapes, or sizes. Metal NPs …

Lung cancer is the leading cause of cancer death in both males and females in the US and
worldwide. Owing to advances in prevention, screening/early detection, and therapy, lung …

Clear-cell renal cell carcinoma (ccRCC) is a common therapy resistant disease with
aberrant angiogenic and immunosuppressive features. Patients with metastatic disease are …

Purpose Lung cancer is the leading cause of cancer-related deaths. The aim of this study
was to design solid lipid core nanocapsules (SLCN) comprising a solid lipid core and a …

Introduction Recent improvements in chemotherapy agents have prolonged postprogression
survival of non–small cell lung cancer. Thus, primary outcomes other than overall survival …

MicroRNAs have been reported to be involved in various biological processes. Here, we
performed a systematic analysis to explore the clinical value and potential molecular …

Breast cancer is one of the most common causes of cancer-related morbidity and mortality in
women worldwide. Early diagnosis and an appropriate therapeutic approach for all cancers …

Erlotinib is effective in NSCLC patients with known drug-sensitizing EGFR mutations, but its
clinical efficacy in patients with wild-type EGFR or acquired resistance to erlotinib remains …